Table 2.

Previous respiratory treatments for COPD in the safety population 6 months prior initiation of the tiotropium/olodaterol Respimat

Previous respiratory treatments	n	%
Number of patients	306	100
Previous treatment with COPD therapy
No	116	37.9
Yes	190	62.1
Respiratory therapeutics
Short-acting beta-2 agonist	13	4.2
Long-acting beta-2 agonist	14	4.6
Short-acting anticholinergic	3	1.0
Long-acting anticholinergic	128	41.8
Short-acting anticholinergic/short-acting β-2 agonist in fixed combination	1	0.3
Long-acting beta-2 agonist + inhaled corticosteroid	63	20.6
Inhaled corticosteroid	11	3.6
Systemic corticosteroid	2	0.6
Theophylline	2	0.6
Prescription of previous respiratory COPD treatment
Continuation of an existing regimen	3	1.0
New prescription at enrollment	1	0.3
Discontinued at enrollment	188	61.4